1. Rheumatic manifestations in malignancy;Matteson;Curr Rheumatol Rev,2008
2. Hospitalization and outcome of systemic lupus erythematosus patients admitted to the Rheumatology ward of Kasr Al-Ainy University Hospital;Kotb;Egyptian Rheumatologist,2023
3. A case of rheumatoid arthritis complicated by a chronic myeloid leukemia associated with pyodermagangrenosum;Mansouri;Egyptian Rheumatologist,2013
4. G. Hernández-Molina Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán , Mexico City, Mexico B. Kostov Primary Healthcare Transversal Research Group, IDIBAPS Department of Statistics and Operations Research, Universitat Politècnica de Catalunya (UPC) P. Brito-Zerón Department of Medicine, Autoimmune Diseases Unit, Hospital CIMA- Sanitas , Barcelona, Spain A. Vissink Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen , Groningen, The Netherlands T. Mandl Department of Clinical Sciences Malmö, Division of Rheumatology, Lund University , Malmö, Sweden A.C. Hinrichs Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht , Utrecht, The Netherlands et al. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies Rheumatology (Oxford). 62 1 2023 2022 243 255.
5. P. Karmacharya A. Donato G.S. AryalM R. Pathak K. Shah et al. RS3PE revisited: a systematic review and meta-analysis of 331 cases ClinExpRheumatol 2016;34:404.